Keywords
Drug Compliance
Teratogens
Congenital Abnormalities
Drug-Induced Abnormalities
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To know the behavior of women in the state of Roraima regarding the use of medications during pregnancy. Methods: Survey using an epidemiological form. Results: Of the total of 158 participants, 37.3% bear children with congenital malformations and 62.7% did not. The mean age (p=0.0380) together with low family income (p=0.0259) between the groups was statistically significant, with women aged between 13 and 25 years old (p=0.0006) are at greater risk of having children with congenital defects. Furthermore, the lack of maternal compliance to drug treatment (p=0.0260; OR: 2.727; CI: 1.156-6.434) was also associated with the development of these abnormalities. In addition, the use of analgesics (p=0.0577; OR: 3.725; CI: 1.070-12.975) and antibiotics (p=0.0588; OR: 2.259; CI: 1.009-5.057) before and during the gestational period, seems to favor the appearance of congenital malformations. Conclusion: Women in the age group of 13 to 25 years old, with income less than or equal to the minimum wage and who do not use medications prescribed during pregnancy, are associated to the development of children with congenital malformations. In addition, the use of analgesics and antibiotics before and during the gestational period seems to favor the appearance of these abnormalities.
References
ANDERSEN JT, et al. Trimethoprim use prior to pregnancy and the risk of congenital malformation: a register-based nationwide cohort study. Obstetrics and Gynecology International, 2013; 2013: 1-9.
ATRASH HK, et al. Preconception care for improving perinatal outcomes: the time to act. Maternal and Child Health Journal, 2006; 10: S3-S11.
BRANNON PM e TAYLOR CL. Iron supplementation during pregnancy and infancy: uncertainties and implications for research and policy. Nutrients, 2017; 9: 1327.
BRONBERG R. Birth prevalence of congenital anomalies in the City of Buenos Aires, Argentina, according to socioeconomic level. Journal of Community Genetics, 2020; 11: 303-311.
CABRAL RD, et al. Antimicrobianos. In: Manual de teratogênese em humanos. Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO); 2011; 45-56.
CARMO TA, NITRINI SMOO. Prescrições de medicamentos para gestantes: um estudo farmacoepidemiológico. Cadernos de Saúde Pública, 2004; 20: 1004-1013.
DEAN JH, et al. Neural tube defects and associated anomalies before and after folic acid fortification. The Journal of Pediatrics, 2020; 226: 186-194.
DONG J, et al. Initiation and duration of folic acid supplementation in preventing congenital malformations. BMC Medicine, 2023; 21: 1-13.
EMORDI VC, OSIFO DO. Challenges of congenital malformations: an African perspective. Annals of Pediatric Surgery, 2018; 14: 1-7.
FLEMING TP, et al. Environmental exposures around conception: developmental pathways leading to lifetime disease risk. International Journal of Environmental Research and Public Health, 2021; 18: 1-18.
FONTOURA FC, CARDOSO MVLML. Association between congenital malformation and neonatal and maternal variables in neonatal units of a Northeast Brazilian city. Texto & Contexto – Enfermagem, 2014; 23: 907-914.
FRANÇA VH, et al. A multiprofessional perspective on the principal barriers to universal health coverage and universal access to health in extremely poor territories: the contributions of nursing. Revista Latino-Americana de Enfermagem, 2016; 24: e2795.
GILL SK, et al. Association between maternal age and birth defects of unknown etiology - United States, 1997-2007. Birth Defects Research Part A: Clinical and Molecular Teratology. 2012; 94: 1010-1018.
GREEN NS. Folic acid supplementation and prevention of birth defects. Journal of Nutrition, 2002; 132: 2356S-2360S.
HAN JY, et al. Unintended pregnancies and exposure to potential human teratogens. Birth Defects Research Part A: Clinical and Molecular Teratology, 2005; 73: 245-248.
HOWSON CP, et al. Controlling birth defects: reducing the hidden toll of dying and disabled children in low-income countries. Disease Control Priorities Project, 2008.
JOHNSON K, et al. Centers for disease control and prevention. Recommendations to improve preconception health and health care - United States/A report of the CDC/ATSDR preconception care work group and the select panel on preconception care. MMWR 2006; 55: RR-6.
KAPAPA M, et al. Risk factors for abdominal wall defects. Congenital Anomalies, 2020; 60: 54-61.
KARAI A, et al. Adverse perinatal outcome in teenage pregnancies: an analysis of a 5-year period in Southeastern Hungary. The Journal of Maternal-Fetal & Neonatal Medicine, 2019; 32: 2376-2379.
KANG G, et al. Adverse effects of young maternal age on neonatal outcomes. Singapore Medical Journal, 2015; 56: 157-163.
MASHUDA F, et al. Pattern and factors associated with congenital anomalies among young infants admitted at Bugando medical centre, Mwanza, Tanzania. BMC Research Notes, 2014; 7: 195.
MALVASI A, et al. Possible long term teratogenic effect of isotretinoin in pregnancy. European Review for Medical and Pharmacological Sciences, 2009; 13: 393-396.
MARIO DN, et al. Qualidade do pré-natal no Brasil: pesquisa nacional de saúde 2013. Ciência & Saúde Coletiva, 2019; 24: 1223-1232.
MEANS RT. Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients, 2020; 12: 447.
MEDAWAR G, et al. Awareness and use of folic acid among women of childbearing age. Annals of Global Health, 2019; 85: 1-6.
MOORE KL, et al. Embriologia básica. 9 ed. Rio de Janeiro: Elsevier, 2016. 311p.
NOGUEIRA-DE-ALMEIDA CA, et al. Além da nutrição – o impacto da nutrição materna na saúde das futuras gerações. 1ª ed. São Paulo: Luiz Martins Editorial Ltda., 2019; 180p.
NORDENG H, et al. Perception of risk regarding the use of medications and other exposures during pregnancy. European Journal of Clinical Pharmacology, 2010; 66: 207-214.
OBEID R, et al. Folate supplementation for prevention of congenital heart defects and low birth weight: an update. Cardiovascular Diagnosis and Therapy, 2019; 9: S424-S43.
PRICE HR, COLLIER AC. Analgesics in pregnancy: an update on use, safety and pharmacokinetic changes in drug disposition. Current Pharmaceutical Design, 2017; 23: 6098-6114.
SILVA LKP, MARQUES AEF. Utilização de medicamentos por gestantes: uma revisão sistemática da literatura. Revista de Atenção à Saúde, 2019; 17: 90-97.
SITKIN N, et al. Congenital anomalies in low- and middle-income countries: the unborn child of global surgery. World Journal of Surgery, 2015; 39: 36-40.
SNIJDER CA, et al. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the generation r study. Human Reproduction, 2012; 27: 1191-1201.
TOMASI E, et al. Qualidade da atenção pré-natal na rede básica de saúde do Brasil: indicadores e desigualdades sociais. Cadernos de Saúde Pública, 2017; 33: e00195815.
VARGESSON N. Review thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Research Part C, 2015; 105: 140-156.
VERMA RP. Evaluation and risk assessment of congenital anomalies in neonates. Children, 2021; 8:1-12.
VIELLAS EF, et al. Assistência pré-natal no Brasil. Cadernos de Saúde Pública, 2014; 30: S85-S100.
WANDERLEY HYC, ARTIGALÁS OAP. Analgésicos e anti-inflamatórios. In: Manual de teratogênese em humanos. Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO); 2011; 95-103.
WANG D, et al. Maternal periconceptional folic acid supplementation and risk for fetal congenital heart defects. The Journal of Pediatrics, 2022; 240: 72-78.
WILSON RD, et al. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. Journal of Obstetrics and Gynaecology Canada, 2015; 37: 534-549.
WU VK, et al. Burden of surgical congenital anomalies in Kenya: a population-based study. Journal of Tropical Pediatrics, 2013; 59: 195-202.
ZHANG XH, et al. Chromosomal abnormalities: subgroup analysis by maternal age and perinatal features in zhejiang province of China, 2011–2015. Italian Journal of Pediatrics, 2017; 43: 1-6.